PortfoliosLab logo
Amedisys, Inc. (AMED)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US0234361089

CUSIP

023436108

IPO Date

Aug 17, 1994

Highlights

Market Cap

$3.12B

EPS (TTM)

$2.71

PE Ratio

35.13

PEG Ratio

1.39

Total Revenue (TTM)

$2.37B

Gross Profit (TTM)

$894.82M

EBITDA (TTM)

$188.85M

Year Range

$82.15 - $98.95

Target Price

$96.17

Short %

7.20%

Short Ratio

6.99

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Amedisys, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


1,000.00%1,200.00%1,400.00%1,600.00%1,800.00%December2025FebruaryMarchAprilMay
1,731.24%
1,090.12%
AMED (Amedisys, Inc.)
Benchmark (^GSPC)

Returns By Period

Amedisys, Inc. (AMED) returned 5.89% year-to-date (YTD) and 4.09% over the past 12 months. Over the past 10 years, AMED delivered an annualized return of 13.17%, outperforming the S&P 500 benchmark at 10.31%.


AMED

YTD

5.89%

1M

4.84%

6M

-1.61%

1Y

4.09%

5Y*

-11.84%

10Y*

13.17%

^GSPC (Benchmark)

YTD

-4.26%

1M

11.24%

6M

-5.02%

1Y

8.55%

5Y*

14.02%

10Y*

10.31%

*Annualized

Monthly Returns

The table below presents the monthly returns of AMED, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20251.88%-0.54%0.68%2.45%1.31%5.89%
2024-0.83%-1.33%-0.92%-0.12%-0.98%0.71%6.81%-0.04%-1.53%-1.98%-3.37%-0.68%-4.49%
202315.71%-4.87%-20.01%9.18%-5.44%20.43%-0.66%3.20%-0.37%-2.04%2.28%1.58%13.79%
2022-16.54%18.61%7.52%-25.91%-9.20%-9.31%14.01%-1.17%-18.29%0.83%-6.66%-8.29%-48.39%
2021-2.05%-11.72%4.40%1.91%-4.25%-5.20%6.41%-29.61%-18.72%13.57%-17.53%15.92%-44.81%
20205.73%-1.41%5.48%0.34%4.28%3.38%17.94%3.31%-2.26%9.55%-5.49%19.83%75.73%
201912.00%-5.23%-0.84%3.70%-12.13%8.10%13.57%-6.66%1.79%-1.90%26.80%2.43%42.53%
20181.73%10.43%1.91%9.53%15.52%11.93%9.56%33.51%-0.04%-11.97%23.86%-14.05%122.18%
20177.48%5.24%5.95%6.09%10.55%4.82%-24.60%10.30%7.12%-14.03%12.24%-2.39%23.65%
2016-9.08%2.77%31.57%6.52%-1.20%-0.77%6.08%-10.12%-1.43%-8.81%-8.71%7.95%8.42%
2015-3.99%7.06%-11.24%3.85%11.54%28.08%9.82%-11.44%-1.73%4.24%2.55%-3.13%33.97%
20143.14%12.39%-12.21%-8.46%6.75%15.05%20.55%3.67%-3.59%29.40%-2.61%15.46%100.62%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of AMED is 58, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of AMED is 5858
Overall Rank
The Sharpe Ratio Rank of AMED is 6565
Sharpe Ratio Rank
The Sortino Ratio Rank of AMED is 5353
Sortino Ratio Rank
The Omega Ratio Rank of AMED is 5858
Omega Ratio Rank
The Calmar Ratio Rank of AMED is 5454
Calmar Ratio Rank
The Martin Ratio Rank of AMED is 6262
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Amedisys, Inc. (AMED) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The current Amedisys, Inc. Sharpe ratio is 0.32. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Amedisys, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2025FebruaryMarchAprilMay
0.30
0.44
AMED (Amedisys, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Amedisys, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-69.40%
-8.35%
AMED (Amedisys, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Amedisys, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Amedisys, Inc. was 91.22%, occurring on May 6, 1999. Recovery took 1101 trading sessions.

The current Amedisys, Inc. drawdown is 69.40%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.22%Jul 5, 1995845May 6, 19991101Nov 5, 20031946
-85.53%Aug 12, 2008871Jan 25, 20121565Apr 16, 20182436
-77.79%Jan 26, 2021544Mar 23, 2023
-34.29%Dec 14, 200548Feb 23, 2006299May 3, 2007347
-32.08%Feb 19, 202019Mar 16, 202021Apr 15, 202040

Volatility

Volatility Chart

The current Amedisys, Inc. volatility is 2.01%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%December2025FebruaryMarchAprilMay
2.01%
11.43%
AMED (Amedisys, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Amedisys, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Amedisys, Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 13.0% positive surprise.


1.001.502.0020212022202320242025
1.25
1.11
Actual
Estimate

Valuation

The Valuation section provides an overview of how Amedisys, Inc. is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for AMED, comparing it with other companies in the Medical Care Facilities industry. Currently, AMED has a P/E ratio of 35.1. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for AMED compared to other companies in the Medical Care Facilities industry. AMED currently has a PEG ratio of 1.4. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for AMED relative to other companies in the Medical Care Facilities industry. Currently, AMED has a P/S ratio of 1.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for AMED in comparison with other companies in the Medical Care Facilities industry. Currently, AMED has a P/B value of 2.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items